Ország: Egyesült Királyság
Nyelv: angol
Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)
Methylprednisolone
DE Pharmaceuticals
H02AB04
Methylprednisolone
100mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT MEDRONE® 100MGTABLETS Methylprednisolone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Medrone 100mg Tablets but will be referred to as Medrone throughout the remainder of the leaflet. WHAT IS IN THIS LEAFLET 1. WHAT MEDRONE IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEDRONE 3. HOW TO TAKE MEDRONE 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE MEDRONE 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT MEDRONE IS AND WHAT IT IS USED FOR This medicine contains methylprednisolone, which belongs to a group of medicines called steroids. Their full name is corticosteroids. Corticosteroids are produced naturally in your body and are important for many body functions. Boosting your body with extra corticosteroid such as Medrone can help following surgery (e.g. organ transplants), injuries or other stressful conditions. These include inflammatory or allergic conditions affecting the: • BRAIN (e.g. tuberculous meningitis) • BOWEL and GUT (e.g. Crohn’s disease and ulcerative colitis) • BLOOD OR BLOOD VESSELS (e.g. leukaemia or arteritis, inflammation of the arteries) • JOINTS (e.g. rheumatic fever) • LUNGS (e.g. asthma, tuberculosis) • MUSCLE (e.g. dermatomyositis and polymyositis) • SKIN (e.g. pemphigus vulgaris, an auto-immune disorder in which the body’s immune system is overactive causing the skin to blister) Medrone may be prescribed to treat conditions other than those listed above. You must talk to a doctor i Olvassa el a teljes dokumentumot
OBJECT 1 MEDRONE 100MG TABLETS Summary of Product Characteristics Updated 25-Apr-2019 | Pfizer Limited • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Medrone Tablets 100 mg 2. Qualitative and quantitative composition Each Medrone Tablet contains 100 mg methylprednisolone. For the full list of excipients, see section 6.1 3. Pharmaceutical form Tablet 4. Clinical particulars 4.1 Therapeutic indications Medrone is a potent corticosteroid with an anti-inflammatory activity at least five times that of hydrocortisone. An enhanced separation of glucocorticoid and mineralocorticoid effect results in a reduced incidence of sodium and water retention. Medrone is indicated for conditions requiring glucocorticoid activity such as:- 1. Collagen diseases/arteritis Systemic lupus erythematosus Systemic dermatomyositis (polymyositis) Rheumatic fever with severe carditis Giant cell arteritis/polymyalgia rheumatica 2. Dermatological diseases Pemphigus vulgaris 3. Allergic states Bronchia Olvassa el a teljes dokumentumot